Clovis Oncology, Inc. Indenture Agreements
6 Contracts & Agreements
- Indenture, dated as of November 17, 2020, by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the New 2024 Notes (Filed With SEC on November 17, 2020)
- Form of Indenture, to be entered into by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the New 2024 Notes (Filed With SEC on November 5, 2020)
- Indenture, dated as of August 13, 2019, by and between Clovis Oncology, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on August 13, 2019)
- First Supplemental Indenture, dated April 19, 2018 (Filed With SEC on April 19, 2018)
- Indenture, dated April 19, 2018 (Filed With SEC on April 19, 2018)
- CLOVISONCOLOGY, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of September 9, 2014 2.50% Convertible Senior Notes due 2021 TABLE OF... (Filed With SEC on September 9, 2014)
